Delivery Order SPE2DB22D3004-SPE2DB25FRM26
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,409.58 firm fixed price delivery order is for the supply of Risperidone 3 mg tablets. The contract has an ultimate completion date of July 18, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,644.11 firm-fixed-price delivery order contract is for the supply of 500 units of the medication Risperidone 2 mg tablet. The contract has an ultimate completion date of February 9, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00...
- This federal contract award is for the delivery of 1 mg Risperidone orally disintegrating tablets, in quantities of 28, to the Defense Logistics Agency (DLA) Medical Supply Chain. The $1,557.90 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2025, with a completion date of July 17, 2025. The contract has no set-aside designation and was competitively awarded. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite...
- This federal contract award, valued at $3,362.76, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of 4,564,222,796 units of Risperidone 2 mg tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation, is the prime contractor on this award. The contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,120.97, is for the delivery of Risperidone 3 mg tablets to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,565.04 contract is for the delivery of Risperidone 3 mg tablets to support federal medical supply requirements, with a completion date of July 16, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of Risperidone 2 mg tablets. The contract has a ceiling value of $1,203.30 and is a Firm Fixed Price Delivery Order with a completion date of May 8, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is leveraging its extensive supply chain network to fulfill...
- This federal contract award, valued at $2,452.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,566 units of Risperidone 1 mg tablets, a medication used for the treatment of mental health conditions. The contract has an ultimate completion date of March 14, 2025 and is structured as a firm fixed-price delivery order, with no set-aside designation....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,295.20 Firm Fixed Price delivery order contract is for the supply of Risperidone 1 mg tablets to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Risperidone 1 mg tablets. The contract has a ceiling value of $3,451.22 and a completion date of April 17, 2025. It is a firm fixed-price contract, and the order was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRM26Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,539.13 firm fixed price delivery order is for the supply of Risperidone 3 mg tablets. The contract has an ultimate completion date of July 17, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medical products and supplies to support military healthcare programs worldwide. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts, potentially involving multiple regional awards, allowing Amerisourcebergen Drug Corp to continue serving government healthcare customers through a flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/16/25 |